Horizon Therapeutics (HZNP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
116.30 +0.05 (+0.04%) 10/05/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 116.30 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 521,482 | 534,491 | 389,796 | 573,020 | -38,380 |
| Depreciation Amortization | 454,476 | 358,940 | 292,091 | 259,759 | 272,510 |
| Income taxes - deferred | 49,814 | -101,016 | -33,453 | -565,537 | -64,491 |
| Accounts receivable | -43,457 | 34,796 | -251,173 | 56,166 | -59,697 |
| Accounts payable and accrued liabilities | 122,232 | -12,197 | 16,015 | -8,723 | -4,593 |
| Other Working Capital | -11,980 | -61,740 | -345,675 | -2,497 | -93,399 |
| Other Operating Activity | 165,275 | 281,997 | 488,087 | 114,144 | 182,593 |
| Operating Cash Flow | $1,257,842 | $1,035,271 | $555,688 | $426,332 | $194,543 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -64,026 | -74,596 | -164,452 | -11,857 | 39,653 |
| Net Acquisitions | -3,122 | -2,843,275 | -262,305 | N/A | N/A |
| Purchase Of Investment | -9,236 | -28,256 | -14,108 | N/A | N/A |
| Sale Of Investment | 4,633 | 3,588 | 794 | N/A | N/A |
| Purchase Sale Intangibles | -62,250 | -51,572 | -30,000 | N/A | -12,000 |
| Other Investing Activity | -62,250 | -51,572 | -24,000 | -6,000 | -12,000 |
| Investing Cash Flow | $-134,001 | $-2,994,111 | $-464,071 | $-17,857 | $27,653 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,574,993 | N/A | 1,525,461 | 818,026 |
| Debt Repayment | -16,000 | -12,000 | -1,739 | -2,150,627 | -845,749 |
| Common Stock Issued | 55,367 | 73,094 | 972,823 | 362,992 | 25,582 |
| Common Stock Repurchased | -250,078 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -137,247 | -165,964 | -66,505 | -28,272 | -14,455 |
| Financing Cash Flow | $-347,958 | $1,470,123 | $904,579 | $-290,446 | $-16,596 |
| Exchange Rate Effect | -2,451 | -10,606 | 7,244 | -107 | -1,380 |
| Beginning Cash Position | 1,584,156 | 2,083,479 | 1,080,039 | 962,117 | 757,897 |
| End Cash Position | 2,357,588 | 1,584,156 | 2,083,479 | 1,080,039 | 962,117 |
| Net Cash Flow | $773,432 | $-499,323 | $1,003,440 | $117,922 | $204,220 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,257,842 | 1,035,271 | 555,688 | 426,332 | 194,543 |
| Capital Expenditure | -64,026 | -76,596 | -169,852 | -17,857 | -4,771 |
| Free Cash Flow | 1,193,816 | 958,675 | 385,836 | 408,475 | 189,772 |